2011
DOI: 10.12968/ajmw.2011.5.1.37
|View full text |Cite
|
Sign up to set email alerts
|

Treating uterine atony with the non-pneumatic anti-shock garment in Egypt

Abstract: Objective: To determine whether the non-pneumatic anti-shock garment (NASG) reduces maternal morbidity and mortality from uterine atony. Method: Women with uterine atony (blood loss of ≥1000 ml) and one clinical sign of shock were enrolled in a pre-intervention phase (n=169) and an intervention phase (n=269) at two referral facilities in Egypt. Differences in demographics, condition on study entry, treatment, and outcomes were examined. Relative risks and 95% confidence intervals (CI) were estimated for mean … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
4
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
3
1
1

Relationship

2
3

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 11 publications
1
4
1
Order By: Relevance
“…After adjusting for pregnancy trimester, MAP < 60 mmHg, uterotonic administration, and MVA, median blood loss was 470 mL less for women in the NASG intervention phase compared with women in the pre-intervention phase. The blood-loss results in this secondary subanalysis of post-abortion hemorrhage cases are consistent with previous findings that the NASG reduces blood loss from all obstetric hemorrhage etiologies as well as when limited only to postpartum hemorrhage etiologies (Mourad-Youssif et al 2010; Morris et al 2011; Ojengbede et al 2011). Studies of the NASG in Egypt and Nigeria examining blood loss from postpartum hemorrhage found that measured blood loss decreased by 50 percent with NASG intervention; women experienced a median blood loss of 400 mL in the pre-intervention compared with 200 mL in the NASG phase (Mourad-Youssif et al 2010).…”
Section: Discussionsupporting
confidence: 90%
See 2 more Smart Citations
“…After adjusting for pregnancy trimester, MAP < 60 mmHg, uterotonic administration, and MVA, median blood loss was 470 mL less for women in the NASG intervention phase compared with women in the pre-intervention phase. The blood-loss results in this secondary subanalysis of post-abortion hemorrhage cases are consistent with previous findings that the NASG reduces blood loss from all obstetric hemorrhage etiologies as well as when limited only to postpartum hemorrhage etiologies (Mourad-Youssif et al 2010; Morris et al 2011; Ojengbede et al 2011). Studies of the NASG in Egypt and Nigeria examining blood loss from postpartum hemorrhage found that measured blood loss decreased by 50 percent with NASG intervention; women experienced a median blood loss of 400 mL in the pre-intervention compared with 200 mL in the NASG phase (Mourad-Youssif et al 2010).…”
Section: Discussionsupporting
confidence: 90%
“…A systematic review of five studies (n = 3,563) of NASG at the tertiary-facility level found a statistically significant reduction in maternal mortality: 39 percent among all women in shock and 58 percent when the analysis was restricted only to women with the most severe shock (El Ayadi et al 2013a). Individual study results, including a subanalysis of the Egypt trial that examined only atonic hemorrhage, also found decreasing trends of similar magnitude for mortality (Morris et al 2011). Among women with postpartum hemorrhage etiologies in Nigeria, NASG was associated with a statistically significant 70 percent reduction in mortality (Ojengbede et al 2011).…”
Section: Discussionmentioning
confidence: 89%
See 1 more Smart Citation
“…This was inconsistent with a prior quasi-experimental study that found no difference between study groups in experience of abdominal pain [42], [43]. While it can be unpleasant, abdominal pain is not a safety concern.…”
Section: Discussioncontrasting
confidence: 57%
“…Before and after studies conducted in different parts of the world revealed a 55% reduction in maternal mortality, 80% reduction in blood loss, emergency hysterectomy decreased from 8.9% to 4.0%, and severe adverse outcomes lessened from 12.8% to 4.1% due to the application of NASG [ 12 15 ]. Evidence-based information from randomized control trials also suggested faster recovery from obstetric shock, decreased maternal mortality, severe end-organ failure, and morbidity after the utilization of NASG [ 16 18 ].…”
Section: Introductionmentioning
confidence: 99%